Engineered domain based assays to identify individual antibodies in oligoclonal combinations targeting the same protein

Quantitation of individual mAbs within a combined antibody drug product is required for preclinical and clinical drug development. We have developed two antitoxins (XOMA 3B and XOMA 3E) each consisting of three monoclonal antibodies (mAbs) that neutralize type B and type E botulinum neurotoxin (BoNT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meng, Q., Garcia-Rodriguez, C., Manzanarez, G., Silberg, M.A., Conrad, F., Bettencourt, J., Pan, X., Breece, T., To, R., Li, M., Lee, D., Thorner, L., Tomic, M.T., Marks, J.D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209713/
https://ncbi.nlm.nih.gov/pubmed/22922799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ab.2012.08.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados